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1.0 ABSTRACT SUMMARY "PATHOPHYSIOLOGY OF SPONTANEOUS VENOUS GAS EMBOLISM"
The discovery of the phenomenon of "Superficial Isobaric Inert Gas
Counterdiffusion Supersaturation" interposed a new and lethal gas lesion
disease between the decompression sicknesses of underwater and aerospace
activity. All three include venous gas embolization as well as generation of
gas lesions in peripheral sites of origin of gas phase, and damage to tissues
in which gas lesions form. Whereas the sites, timing and duration of gas
lesions in the two decompression-related conditions are unpredictable, gas
lesion location and degree in isobaric counterdiffusion are controllable, as
is the degree and duration of its stable rate of continuous venous gas
embolism.
This program concerned the use of controllable degrees and durations of
continuous isobaric counterdiffusion venous gas embolism to investigate
effects of venous gas embolism upon blood, cardiovascular, and respiratory gas
exchange function, as well as pathological effects upon the lung and its
microcirculation.
Use of N£)/He counterdiffusion permitted performance of the pathophysiologic
and pulmonary microstructural effects at one ATA without hyperbaric or
hypobaric exposures.
One component of the program entailed tracking of pathophysiologic effects of
venous gas embolism leading to death. In a shorter duration of the same
degree of continuous venous gas embolism examination was made for effects of
blood/gas phase interactions on blood contact system. A lesser degree of
multi-hour pulmonary venous gas embolism was used to investigate pathologic
effects of isobaric venous gas embolism upon lung microstrueture.
An initial intent of the program included determination of interaction between
pulmonary damage by venous gas embolism and pulmonary effects of oxygen
poisoning, as this might relate to hyperbaric therapy of severe decompression
sickness.
Continuous venous gas embolism associated with whole body (head and neck
excluded) counterdiffusion of artificially respired animals was tolerated for
1 to 4 hours without major cardiovascular or hematologic effects, except for
early death in two animals which had patent interatrial septal defects. Death
of other animals after prolonged counterdiffusion and venous gas embolization
was associated with hemoconcentration, plasma loss, hypotension, metabolic and
respiratory acidosis, and arterial hypoxia and hypercapnia in the face of
constant artificial .ventilation.
Absence of detectable pulmonary damage by the venous gas emboli of isobaric
counterdiffusion made study of interaction of interaction with therapeutic
degrees of oxygen poisoning not practical. An alternative investigation
established that intra-atrial continuous infusion of air bubbles did produce
pulmonary microvascular injury in pigs whereas the isobaric counterdiffusion
venous gas embolization did not.
2.0 INTRODUCTION AND BACKGROUND
Venous Gas Embolism (VGE) directly relevant to NASA missions occurs in
human subjects exposed to ambient pressure reduction in hypobaric chambers, in
simulation of operational hypoberic profiles associated with extra-vehicular
activity (EVA) in the space environment, in high altitude aviation, and in
decompression from prolonged exposures to compressed air breathing in
underwater neutral buoyancy simulation. The classical procedure of oxygen
breathing has been extensively investigated to accelerate nitrogen elimination
and prevent venous gas embolism and symptoms of hypobaric decompression
sickness (11)(22).
The long (multi-hour) periods of oxygen breathing required to prevent
decompression sickness and/or venous gas embolism impose considerable
operational restriction, as well as potential cumulative effects of oxygen,
especially in relation to daily repetetive EVA from a one atmosphere space
compartment (11)(22).
Since venous gas embolism can occur without symptomatic expression of
decompression sickness, it has been necessary to determine the characteristics
and significance of any physiologic or pathophysiologic effects produced by
the gas embolic process. In such investigation it is also necessary to
distinguish' among several different forms of venous gas embolism used in
experimental procedures (14).
2.1 Forms of Venous Gas Embolization (VGE)
Common features of operational or experimental venous gas embolization
include any effects upon blood itself, physiologic changes effects on lung
tissue or pulmonary vasculature, and potential for transpulmonary embolism of
the arterial system and the entire body system it supplies.
Important differences among the several recognized forms of venous gas
embolism, each encountered operationally and used experimentally, include:
(a) Decompression from transient (non-saturating) hvperbaric exposures
(e.g. Diving). All body tissues are exposed to increased inert gas pressures
during hyperbaria, to different degrees in myriad sites. Improper
decompression procedures can presumably produce VGE from any or all
undefinable foci of generation (14). VGE formation is transient and
unpredictable in onset, degree or duration. Effects of such gas emboli are
therefore unpredictable pulmonary arterial blood, derived from the venous
drainage of all tissue sites, is supersaturated unless specific measures (e.g.
oxygen breathing) are taken to prevent this.
(b) Intentional or accidental infusion of air into venous blood stream
(e.g. experiment or clinical procedure). Body tissues and venous blood
normally have sub-atmospheric total gas pressure. Bubbles of infused venous
gas emboli, not having generated in peripheral tissues, do not produce
products of peripheral tissue damage.
(c) Decompression from normal air breathing at one atmosphere to
hypobaric states (e.g. altitude exposure, chamber experiment, EVA) (11).
Decompression is from a state of nitrogen saturation of all tissues, including
tissues with slowest rates of gas elimination. This circumstance is
dynamically equivalent to a-, decompression from hyperbaric nitrogen saturation
(as in ascent from multi-day shallow air saturation' diving) . VGE is
prolonged, but unpredictable in onset, degree or duration.
(d) Deep Tissue Isobaric Inert Gas Counterdif fusion (e.g. breathing
different inert gases in sequence) (14) (8). VGE are generated when helium is
breathed at high ambient pressures following prolonged exposure to nitrogen-
oxygen atmospheres. Gas supersaturation is transient, in all tissues. VGE
onset, degree, duration and sites of origin are unpredictable.
(e) Superficial Isobaric Inert Gas Counterdiffusion (e.g. Breathing air
by mask in a helium-filled diving bell) . Supersaturation of superficial skin
tissues without compression or decompression (isobaric state) leads to dermal
and subcutaneous gas lesions, and venous gas emboli (7) (12) (14) (15) (19) . In
the stable counterdif fusion environmental situation the volume rate of venous
gas embolism begins early, continues at an essentially uniform stable rate
throughout the counterdif fusion exposures, with its degree proportional to the
exposed surface area. Specific microsites of gas emboli are not known.
Venous blood delivered to pulmonary arterial circulation comprises venous
blood of unsaturated inert gas composition from all deep tissues, mixed with
supersaturated blood from the counterdif fused superficial tissue. The inert
gas composition of the mixed venous blood is therefore not precisely
predictable, any more than it is in decompression (14).
2 .2 Isobaric Counterdiffusion As An Experimental Model for VGE Pathophysiology
Superficial Isobaric Inert Gas Counterdiffusion was selected in contrast
with intravenous gas infusion as the method for inducing venous gas embolism
of the lung in the present project because:
s^ emboli are generated in peripheral tissues , as they are in
decompression sickness. Occurrence of local tissue damage, patterns of
"Bubble" size, pathways of transit to lung, and contact with blood, are
all relevant to hypobaric decompression phenomena.
Formation of gas emboli is spontaneous, from supersaturation tissue or
blood.
Degree of venous gas embolism is controllable and stable, aiding dose-
effect study.
Duration is prolonged, aiding duration- effect study.
Stable VGE rate is adaptable to study of gas lesion therapy (reversal) .
3.0 PROJECT GOALS AND SCOPE
3.1 Initial Plan - For Sequential Program:
The planned goals of the overall program included:
(a) Primary determinations of the pathophysiologic character and
development rate of pulmonary tissue damage and transpulmonary gas
embolism induced by counterdiffusion venous gas embolism.
(b) Determination of effects of prior acute pulmonary oxygen poisoning
on VGE-induced pulmonary pathology.
(c) Determination of volume and mass rates of VGE induced by isobaric
counterdiffusion in hypobaric states, for comparison with normobaric and
hyperbaric states.
The expanded scope, specific findings and duration of the primary
(pathophysiologic) investigations made it desireable and necessary to place
entire emphasis upon this cited Primary Goal (and its hypothesis that
"Progressive Microvascular and Other Pulmonary Damage Will Result From
Continuous Isobaric Supersaturation Venous Gas Embolism").
The stated ancillary goals, each with a scope larger than the
examination of VGE effects on normal lung, will require specific additional
investment.
3.2 Scope of Report
This Report provides (a) results of interrelated investigations of
cardiorespiratory, hematologic and pulmonary effects of continuous
counterdiffusion gas embolism, and (b) contrast of pulmonary histopathologic
effects of isobaric counterdiffusion and air injection venous gas embolism.
4.0 METHODS OF VGE EXPOSURE AND MEASUREMENTS
Details of isobaric exposure and control conditions, monitoring and
specific measurement methods are defined in the expanded description of
Appendices A, B and C. Most physiologic measurements were common to each
major series of experiments.
4.1 Isobaric Counterdiffusion VGE Generation
. Young Yorkshire Piglets, anesthetized with I.P. Na pentobarbital, were
artificially ventilated at stable level for one to two hours with a near-
normoxic N;p-02 mixture in an air environment. While continuing N^D-02 a large
or smaller area of the body surface was enveloped by a plastic bag and exposed
to helium flow at 1.0 ATA. Initiation of VGE was detectable at an average of
about 80 minutes from the beginning of helium exposure, as monitored by a
doppler bubble detector cuff about the inferior vena cave. VGE continued
until death of the animal or other termination of the experiment (Appendix B).
4.2 Monitoring and Measurements for Cardiovascular and Respiratory Effects.
Volume-controlled artificial respiration was maintained via surgically
implanted tracheal cannula, at a tidal volume and respiratory rate providing
an initial 36 to 40 mm Hg end-tidal PCC>2 (Appendix B). Indwelling catheters
were used for blood pressure monitoring, fluid infusion, and blood sampling.
A Swan Ganz catheter inserted via the right external jugular vein into a
branch of the pulmonary artery provided for periodic thermodilution
measurement of cardiac output, and continuous measurement of pulmonary artery
pressure. Body temperature of the thermally-supported animal was continuously
recorded from a rectal thermistor probe, heart rate from electrocardiograph
lead II.
4.3 Sampling and Measurements of Blood Functions
Respiratory, Coagulation, Cellular Composition and other characteristics
of blood were determined in different experiments series, as described in
detail in Appendices B and C. Timing of blood function sampling related to
the goals of specific exposure series. Common sampling and measurement
procedures included:
Hematologic measurements. Blood samples obtained via external
jugular venous catheter were analyzed by Automatic Cell Track 560 for
hemoglobin concentration, hematocrit, white cell total and differential
counts and platelet counts. Counts were normalized to hemoglobin
concentration.
Blood oxygen and carbon dioxide partial Arterial pressures and pH
were measured on heparinized samples, using Corning 165/2 electrodes,
Radiometer Precision Buffers and Laboratory validated oycc>2 gas
mixtures. Values were corrected,to measured rectal temperature.
Coagulation Factors were measured as described in Appendix C, on
venous blood samples collected in sodium citrate with e-aminocaproic acid.
4.4 Pulmonary Microcirculation - Serial Biopsy of Lung Tissue. During
Continuous Venous Gas Embolism
Biopsies of the right lung were taken at 0, 2 and 6 hours of stable
venous gas embolism, through two right-sided thoracotomy incisions (10th, 6th
interspace), made and sealed during initial experiment preparation. The left
lung remained undisturbed, for use in post-experiment necropsy studies.
Biopsies and necropsy lung samples were processed for Light and Electron
Microscopy histologic examinations (Appendix D). '
5.0 PATHOPHYSIOLOGIC EFFECTS OF VGE
Effects of VGE on cardiovascular/respiratory functions, blood functions
arid pulmonary microstructure are summarized separately here, and elaborated in
Appendices.
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5.1 Whole Trunk and Extremities. Lethal Counterdiffusion (Appendix B).
Counterdiffusion exposure of full trunk and extremities was used to
investigate cardio-respiratory pathophysiologic changes leading to death.
Initial experiments, limiting counterdiffusion to hindquarters, generated
cutaneous gas lesions but did not produce definitive and progressive changes
in measured cardio-respiratory indices up to 18 hours of NjO/He/1 ATA
exposure.
Venous gas embolism did not occur prior to visible cutaneous changes
associated with development of gas lesions. Vena Caval Doppler signals of gas
embolism began at an average lag of 1.5 hrs. from the initiation of
counterdiffusion. Cutaneous lesions and VGE signals continued through the
over ten hours average time (range 5.4 to 28.0 hours) of survival.
Patent atrial septal defect. Special importance is given to one animal,
which died abruptly after only 30 minutes of N^y^e counterdif fusion.
Necropsy showed a patent atrial septal defect, and the animal was not included
in the primary series of 8 normal animals.
Cardiovascular effects. No significant cardiovascular changes occurred
until onset of VGE, when pulmonary artery pressure increased from a control
value of about 17 mm. Hg to about 28 (Figs. 1 and 2, Table 1). It remained
elevated throughout counterdiffusion, until the circulatory failure related to
death. Pulmonary capillary wedge pressure, indicative of left atrial
pressure, remained at or below normal. Heart rate rose progressively, with
decrease in cardiac output. Rise in hematocrit and hemoglobin concentration
indicated hemoconcentration and decrease of plasma volume (Figs. 3 and 4).
Most animals developed a systemic arterial hypotension 1 to 2 hours prior to
death.
The composite effect appeared to be that of peripheral circulatory
damage, with loss of circulating blood volume (2), decrease in cardiac output,
and peripheral hypoxia, paralleled by decrease in pulmonary-arterial gas
exchange,, with resultant arterial hypoxia and hypercapnia (Table 1). Because
artificial ventilation was maintained, final failure is considered to have
been cardiovascular. Without the continuous artificial ventilation, which was
a necessary condition of the several experiment series, death would have
occurred within one to two hours, as in earlier investigations of the
counterdiffusion mechanism (12)(19).
Arterial Blood PC>2. PC02 and pH. In spite of constant volume rate of
artificial respiration and periodic pulmonary inflation to counter
atelectasis, counterdiffusion induced progressive arterial hypoxia,
hypercapnia and increased hydrogen ion concentration (Table 1, Figs. 7 and 8).
These changes were evident at one and four hours of gas embolism, indicating
development of hypoxic lung units. The composite effect on arterial blood
represented a combined "metabolic" and "respiratory" acidosis.
5.2 Effects on Blood Components and Systems (Appendix C).
Effects of continuous venous gas embolism on blood were determined
during the initial and early stages (one to four hours) of the active
counterdiffusion process. Venous blood was sampled for measurements of cells,
hemoglobin and functional activity of contact factors. Values of white cell
and platelet counts (Figs. 5 and 6, Table 1) were normalized to baseline
hemoglobin concentration to take change in plasma volume into account.
Observations relevant to VGE and other gas lesion development included:
Hemoglobin concentration and Hematocrit increased at one and four hours.
Plasma volume change (Calculated from increased Hb and hematocrit)
was estimated to have been reduced 15% at one hour and 26% at 4 hours of
VGE.
White cell and platelet counts did not change significantly from
baseline levels for all animals at one hour of exposure. However
platelet counts were clearly- decreased in longer exposures. The platelet
aggregation phenomena described elsewhere could not be studied in this
project (17).
Significant changes related to blood contact system or coagulation
did not occur in normalized values for a PIT, PT, Fibrinogen levels or
functional activity of Factors XII, XI, PK and Hmwk at 1, 4 and 6 hours
of counterdiffusion (Table 1). The effects of low level superficial
isobaric counterdiffusion with venous gas embolism may differ at least
in degree from severe, generalized decompression sickness.
5.3 Effects on Lung and Pulmonary Microstructure
Studies performed relative to effects of VGE upon lung were made for
primary isobaric counterdiffusion information and for comparison with the
several other investigations involving pulmonary effects of controlled intra-
atrial air infusion (1)(5)(10)(13)(16)(18)(21)(23). The present program
included pulmonary hemodynamics, circulating leukocytes, pulmonary edemia,
broncho-alveolar lavage for cells and protein, and morphologic studies of
gross lung, pulmonary microstructures, and ultrastructure of pulmonary
capillary endothelium. Findings included:
Rise in pulmonary arterial pressure occurred at onset of VGE. No
indication was found that this prompt rise is not primarily caused by
physical obstruction of pulmonary arterioles and capillaries.
Pulmonary edema development was not evident from gross or
microscopic examination. Lung "wet to dry weight ratio" at death was
not different from control, unembolized animals.
Broncho-alveolar lavage performed sequentially after one and four
hours of counterdiffusion venous gas embolism showed no significant
changes in protein content or number or types of cells.
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Light microscopic examination showed preservation of normal
microstructure, with no evidence of capillary blockage by gas "bubbles".
Systematic electronmicroscopic examination of sequential biopsy and
post-mortem lung tissue showed no evident pulmonary histopathology,
leukocyte or platelet .aggregations, or trapped gas emboli in exposures
to prolonged, spontaneous counterdiffusion venous gas embolization of
the lungs. This is in contrast to prior observations with intra-atrial
air infusion in sheep and dogs (Table 2) (1)(16)(Appendix D).
Air bubble infusion into the right atrium of pigs, at the size and
rate found in sheep to develop rise in pulmonary artery pressure used in
the continuous lower body counterdiffusion studies in pigs (1), produced
much more severe pathophysiologic effects in the pig than when used in
sheep (i.e. gross elevation of pulmonary arterial pressure, hypoxemia,
and passage of gas bubbles through the lungs into the arterial
bloodstream, in the absence of cardiac septal defect). Air infusion has
been now widely used in several different mammals (rabbit, dog, sheep,
pig) for study of effects on transpulmonary passage of gas emboli and
microvascular structure (1)(3)(5)(6).
Use of air bubble infusion in the pig at a rate about one tenth that
customary for pulmonary embolism experiments in sheep produced the
stable, 300 to 500% increase of pulmonary arterial pressure
intentionally generated for the counterdiffusion venous gas embolism
studies. With this lower rate or air infusion the histopathologic
effects on pig lung microcirculation resembled those seen in sheep
infused with the larger rate of air infusion required to produce the
equivelent sustained increase.in pulmonary artery pressure.
6.0 SUMMARY INTERPRETATIONS
Correlation of results from the several series of venous gas embolism
experiments has provided a quantitative pattern of early pathophysiologic
effects, their progression, and events preceding death. Lung biopsy and
necropsy,.findings provide visible indexes of the presence or absence of lung
microvascular microstructural change associated with continuous gas embolism
of extreme degree and duration. Conclusions from these measurements and
visual observations, to be elaborated in detailed open publications, include:
6.1 Survival
When the entire area of trunk and extremities (excluding only head and
neck) is exposed to N^ O/He/l ATA counterdif fusion, a near maximum degree of
spontaneous, peripherally generated one ATA counterdiffusion venous gas
embolism, pulmonary embolic bombardment, and bubble-venous blood interaction
should be generated. In this situation, cumulative effects and
pathophysiologic changes are not all clearly evident early (e.g., one hour),
but become larger and even lethal in prolonged, continuous exposure.
Survival during such near-maximum exposure can approach ten hours.
Survival during small degrees of continuous venous gas embolism can probably
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be considered practically unlimited in normal animals. Survival in the
presence of patent atrial septal defect can be brief, with sudden death early
in counterdiffusion. Any degree of detectable arterial gas embolism must be
considered serious (9).
Approximately 30% of animals exposed to entire trunk/extremity
counterdiffusion until death demonstrated visible left-sided gas embolism at
gross necropsy.
.,2 Development of cutaneous gas lesions and venous gas emboli.
Doppler indication of initiation of VGE in every instance followed
development of skin lesions. Lag in development both of skin lesions and VGE
was unrelated to area of superficial counterdiffusion. The degree of venous
gas embolism is known to be related to the area of counterdiffusion, the gas
species, and partial pressure gradients (14).
6.3 Cardiovascular Effects
Continuous venous gas embolism generated a rise in pulmonary artery
pressure, proportional to surface area of counterdiffusion and persistent
until ultimate systemic circulatory failure.
Systemic arterial blood pressure was initially sustained by increase in
peripheral vascular resistance, even with progressive decrease in cardiac
output. Pulmonary venous pressure (pulmonary capillary wedge pressure)
remained normal until terminal cardiac failure.
6.4 Blood Cellular Composition
The gradual increases in hematocrit and hemoglobin concentration
indicate a decrease in plasma volume. In the absence of pulmonary edema this
was most probably related to the extensive tissue damage at sites of
superficial gas lesion development.
While total white cell concentration did not change, the proportion of
neutrophils did increase. The basis and importance of this is not known.
Thrombocytopenia may have begun early in counterdiffusion gas embolism,
but it became significant in degree only late in the prolonged gas embolism
experiment exposures.
_,•
6.5 Lung microstructure. cells and extravascular water.
The principal conclusion is that prolonged sub-lethal degree of isobaric
counterdiffusion VGE (e.g., lower half of body) does not cause microembolic
injury to the lungs, compared with the prominent defects produced by direct
air infusion into mixed venous blood.
Counterdiffusion venous gas embolization of the lungs (lower half of
body only), even after causing four hours of sustained pulmonary arterial
hypertension, produced no visible intra-capillary trapped gas emboli, or gross
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or interstitial edema, or micro-damage to alveolar capillary endothelium.
Each of these pathogenic events occurs on right atrial infusion of air into
air breathing sheep (1). The implication is that major pathophysiologic
effects of counterdiffusion gas lesion disease, like initial degrees of
decompression gas lesion disease, are related to peripheral and systemic
(extra pulmonary) sites.
An explanation is not now obvious for this important difference in
pulmonary effects between air embolus infusion during air breathing and N^D/He
counterdiffusion gas embolism, especially in the face of the experiment
conditions of imposed equivalent influence upon degree of induced pulmonary
artery hypertension.
Considerations of differences in addition to composition include the
size ranges of venous gas emboli, the volume rate of gas emboli of different
size range, and dynamic persistence of individual gas emboli in the hundreds
of thousands of units of lung microvascular targets.
"Persistence duration" for trapped emboli is related to the gas pressure
gradient between gas embolus and adjacent alveolar gas space, and to
diffusivity characteristics of gases involved (20) (primarily nitrogen,
nitrous oxide and helium, since 02 and C02 pressures should be only little
different in the two forms of experimental gas embolism). It has been shown
that rate of intra-pulmonary resolution of air microemboli is affected by
respiration of other gases (20). In the present project the respired gas
mixtures were stable, and the approximate composition of the venous gas emboli
was known from prior experiments (14).
In air infusion into an air breathing, nitrogen saturated animal, the
nitrogen partial pressures in venous blood, venous gas emboli and alveolar gas
space will not differ greatly (20). Therefore rates of resolution of gas
emboli trapped in pulmonary microvessels should be slower for air infusion
than for emboli containing inert gas species other than those inspired. The
experimental condition of N^ /He/l ATA isobaric superficial counterdiffusion
involves: prolonged (near equilibrium) respiration of N20-02, residual levels
of nitrogen in all tissues including venous blood, and entry of helium into
cutaneous venous blood by diffusion.
Venous gas emboli to the lung in the counterdiffusion state therefore
contain N^D, N2 and He as well as 02, CC>2 and H^ (14). Inspired gas
ventilating the alveoli contains only.N^ as the oxygen vehicle. The
essentially full outward gradient for the gas embolus nitrogen and helium
should initiate and accelerate an embolus collapse process, toward complete
resolution or toward prompt passage of a resulting smaller microbubble through
the pulmonary arteriole and capillary, to the arterial bloodstream.
Such an effect would be even more accelerated in the situation of oxygen
breathing during or after venous gas embolism generated by any means,
including hypobaric decompression or decompression from hyperbaric states.
Size range of spontaneous micro-gas emboli would also be important to duration
of entrapment in these forms of decompression venous gas embolization.
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6.6 Respiratory Gas Exchange
Under constant volume pulmonary ventilation, intended to maintain an
experiment condition of stable arterial PC>2 and PCC>2, venous gas embolism
caused a progressive rise in arterial PCC>2, fall in arterial PC>2, and increase
in arterial hydrogen concentration. In the absence of evident pulmonary edema
or histologic signs of lung damage, the observed changes in arterial PC>2 and
PCC>2 (Figures 7 and 8) are more likely due to ventilation/perfusion mismatch
than to lung microstructural injury or acute microinflammatory responses.
6.7 Transpulmonary Gas Embolism
It is probable that three extremes of transpulmonary gas bubble passage
occurred in the continuous counterdiffusion venous gas embolism exposures of
this project.
One was the early and promptly fatal passage of gas emboli through an
identified inter-atrial cardiac septal defect, into the arterial bloodstream.
The second observation was the occurrence of grossly visible arterial
gas emboli generated only in the final stages of survival, after hours of an
essentially constant degree of counterdiffusion venous gas embolism to the
lungs. This resembles the now recognized occurrence of visible and Doppler
detectable transpulmonary embolism at large rates of intra-atrial air
injection, overloading a pulmonary "filtering" capability (3)(1)(21). Visible
arterial gas emboli, with inevitable access to all tissues, were seen in
coronary and other arteries in the gross necropsy examinations of these
experiments. Effects on organ function of such visible arterial emboli have
to be prominent or fatal.
The third kind of-necropsy observation, made also in many previous
N^ D/He/l ATA counterdiffusion studies (14), was the occurrence of gas
"bubbles" in the venous blood of individual organs such as kidney, heart or
intestine. Since deep organs are not subjected to superficial
counterdiffusion this occurrence is considered as indicating passage of micro-
emboli through the lungs into arterial blood, and then to and through all
organs and tissues, with possible recirculation until resolution or growth.
An ancillary probability is that such diffusely distributed micro-emboli may
grow in size after death or in any decreased tissue blood flow, where tissue
and organ venous blood are for any reason supersaturated (as in deep tissue
counterdiffusion or decompression states). Expansion after death may
represent a unique expression of a magnification of the size of gas emboli
which would in life be again presented to the lung for filtering. The
relation of nitrous oxide breathing to this post-mortem growth of "arterial or
deep tissue gas bubbles" is probably highly important.
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8.0 FIGURES and TABLES - Continuous Isobaric Counterdiffusion
(Individual Effects, 8 Animals)
Figure I. BLOOD PRESSURES AND HEART RATE
(Mean Arterial BP, Mean Pulmonary Artery BP,
Mean Pulmonary Wedge Pressure
Figure 2. CARDIAC OUTPUT
Figure 3. HEMOGLOBIN
Figure 4. HEMATOCRIT
Figure 5. TOTAL WHITE BLOOD CELLS
Figure 6. PLATELETS
Figure 7. ARTERIAL P02
Figure 8. ARTERIAL PC02
Figure 9. CONTINUOUS VENOUS GAS EMBOLISM
Table 1. Detection of Lesions in the Lung Microcirculation in
Anesthetized Pigs .with Counterdiffusion and Air Infusion
Venous Gas Emboli
Note: Changes During Lethal Counterdiffusion Venous Gas Embolism.
Generated by Trunk and Limb Exposure.
Effects Are Referenced to Pre-Counterdiffusion Control State.
Plotted Values Represent Trend to last Measurement before Death
Measurements Interpolated to Common Times To aid Statistical
Correlation of Effects Relative to Exposure Duration.
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Table 1
Detection of Lesions' in the Lung Microcirculation in Anesthetized Pigs
with
Counterdiffusion and Air Infusion Venous Gas Emboli
Condition Number
of
Animals
Pulmonary
Arterial
• Microvessels
No. Lesions
Pulmonary
Venous
Microvessels
No. Lesions
Alveolar
Capillaries
No. Lesions
Group I
Counterdiffusion 5
Group II
Venous air embolization 3
Group III
Control Air Breathing 5
50
50
50
0
34
50
50
50
250
150
250
0
Data are shown as the total number of vessels (No.) and endothelial lesions (gaps) within those
vessels. 10 pulmonary arterial and venous vessels and 50 alveolar capillaries each were analyzed
per pig in Counterdiffusion and control groups. Additional arterial and venous vessels were
analyzed in air infusion group.
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RELATIONS OF ISOBARIC GAS COUNTERDIFFUSION AND DECOMPRESSION GAS LESION DISEASES
C.J. Larabertsen, M.D.
Institute For Environmental Medicine
University of Pennsylvania Medical Center
Philadelphia, PA 19104-6068
Purpose and Perspective
A personal goal at this Conference is to use the information and
concepts of isobaric counterdiffusion to bind together three key
elements determining decompression safety. These elements, which cannot
sensibly be separate in diving, still tend often to be considered
separately. They are the oxygen effects (1), the several forms of
isobaric inert gas exchanges (2) (3) (4) and the forms of decompression-
induced inert gas elimination (1).
Oxygen simultaneously provides: the most predictable physical aid to de-
gassing, a complex of physiologic forces which conceivably modify
decompression-relevant de-gassing process, a component of gas spaces or
emboli, and variable forms of toxic effect which conceivably can modify
decompression-relevant degassing. Only the positive (the physical) role
has been specifically demonstrated.
Decompression Gas Elimination would do no harm in the absence of free
gas phase growth.
Isobaric Inert Gas Counterdiffusion can aid degassing or it can
interfere with degassing during decompression. It can generate stable
or transient gas supersaturation, gas lesions and gas emboli at stable
ambient pressures, or it can generate transient subsaturation.
The relationships of oxygen, decompression and counterdiffusion are
clear on conceiving a decompression or therapy as a series of
instantaneous (isobaric) periods in which all ongoing forms of gas
exchange and gas effect exist simultaneously (as they do in reality).
A second personal goal is again to urge use of the term "Gas Lesion
Diseases," devised to encompass the several overlapping and impure
pathologic states now obviously related and sometimes concurrent in
exposures to unusual pressures and atmospheres (2). The still
conventional blanketing designations of "Decompression Sickness" or "Gas
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Embolism" are not adequate for present and future diving or hyperbaric
medicine, and have led to use of such foolish terminology as "isobaric
decompression sickness."
Table 1 indicates the scope of major forms of gas lesion diseases,
different in their inducing circumstances or their consequences. The
resulting symptoms or objective signs (e.g. neural, vestibular,
cutaneous, or local pain may be similar or different, and do not
themselves describe or represent the specific disease or fundamental
mechanism. Table 2 emphasizes the clearly obvious fact that the
ultimate primary basis for gas phase generation in decompression or in
isobaric gas lesion diseases is an excess pressure of gases in^ w,
peripheral tissues including peripheral blood. The complex consequences
of bubble growth and bubble-tissue interactions are sequels to the
primary event, without which no pathologic effects would occur. The
table also emphasizes that the very occurrence of gas lesions and
emboli in isobaric states indicates the pre-existence or continuous
formation of "nuclei" in normal tissue fluids. Asterisks (*) mark
venous gas embolism in four of the forms of gas lesion disease to call
attention to the possibility that venous gas embolic process may
conceivably lead to arterial gas emboli. While venous gas emboli affect
blood and lung, arterial gas embolic phenomena should be considered as
having access to all tissues and arterioles. It is therefore here cited
as "systemic" embolization.
Table 1.
SOURCE OF
HAJOR FORMS OF GAS LESION DISEASES CftS. PHASE
Pulmonary overexpansion Lung
Systenlc Gas Embolism (Arterial)
Pneuoothorax
Subcutaneous/Hedlastinal Emphysema
latrogenic or Traumatic Gas Embolism Extrinsic
Venous*
Arterial
Systemic (Arterial)
Decompression Sickness (Post Hyperbaric, Hypobaric) Peripheral Tissue
Cutaneous
Deep Tissue
Venous Embolic*
Systemic (Arterial)
Superficial Isobaric Counterdiffusion Sickness (Stable State) Peripheral Tissue
Cutaneous
Vestibular
Venous Embolic*
Systemic (Arterial)
>
Deep Tissue Isobaric Counterdiffusion Sickness (Transient) Peripheral Tissue
Venous Embolic*
Systemic (Arterial)
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Table 2.
GAS PHASE DEVELOPMENT IH DIVING DECOMPRESSION AND ISOBARIC COUNTERDIPPU5IOH
Inert gas uptake is not hamful in diving, inert gas elimination is not
harmful, and dacoapreasion itaelf la not harmful.
Gas phase development is the pathophyoiologic event, whether nicroscopic or
gross. It is itaelf the result of an elevation of tissue inert gas pressure
above anbient.
It is Bost probable that gas lesion development results froa growth of
normally present gas nuclei, as Indicated by the isobaric development of gas
lesions at one ATA, without prior compression or decompression.
Gaa lesions do not produce detectable symptoms or objective signs at all
target sites.
At any aite, symptoms and objective signs require time to develop after gas
phase development has begun.
The more conservative the limitation of degree of inert gas excess, the less
severe should be the degree of symptoms or objective signs, of any type at
any site.
Localization of gas phase development.
Some effects of early stages of isobaric gas phase development are
precisely visible in experiment. Most of those for early stages of
decompression sickness are not. Like the Counterdiffusion processes,
decompression sickness (excluding pulmonary barotrauma) is not a single,
"yes or no" event or "threshold" phenomenon. It is potentially a
generalized systemic process of gas phase separation and expansion,
which may become severe enough in some microanatomical locations to be
clinically diagnosed. It can probably simultaneously go unrecognized in
many different other locations. Decompression sickness, like the
Counterdiffusion processes, is surely a diffuse continuum of graded
degrees of pathophysiologic event and effect, simultaneously occurring
in many scattered tissue locations, each of which has its own local
"stress-effect" consequences. Categorical designations of decompression
sickness effects, as for example into Type I and Type II, have been
medically and operationally practical. However, they are not
descriptors of the fundamental, decompression-induced systemic
processes, or the manner in which they can be expected to be aggravated
by forms of isobaric Counterdiffusion (1) (2).
Against the license of these "Perspectives" the following review will
emphasize empirical observations in experiments with isobaric
counterdiffusions.
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Table 3.
ISOBARIC INERT GAS COUKTERDIFFUSION (Superficial and Deep Tissue Forms)
Two forma of iaobarlc counterdiffuslon superaaturatlon can produce gas lesions
or venous gas emboli.
•Superficial" isobario counterdiffusion occurs through body surfaces when
air or N2-O2 is breathed and the external environment is heliua.
•Deep tissue" isobaric counterdiffusion occurs when any different inert gases
are breathed in sequence.
Bach fora of isobaric counterdiffusion can lead to inert gas suoarsaturatlon of
involved tissues. This supersaturatlon and gas embolua formation is now
entirely preventable, by proper choice of operational gases and sequences.
Each fora of isobaric generation of supersaturations can potentially
exaggerate a concurrent decompression supersaturation and related gas lesions.
Each form of isobaric counterdiffusion can lead to inert gas subsaturation of
involved tissues. This result is operationally and therapeutically useful.
"Isobaric" gas exchanges of all types should be considered as able to occur in
the course of decompression procedures, as well as at stable pressures.
Hyperoxygenation therapy is rational for isobaric counterdiffuaion gas lesions,
as 'it is for gas lesions of decompression sickness.
AMBIENT HELIUM-OXYGEN ENVIRONMENT
Ht • 9.800 mm Hg
FACTORS IN DEVELOPMENT
OF SUPERSATURATIONSUBCUTANEOUS
OAS PHASE GAS PRESSURE GRADIENT
CAS SOLUBILITY IN
TISSUE CONSTITUENTS
DIFFUSIVITV OF OASES
TEMPERATURE (AMBIENT
AND TISSUE!
SKIN CHARACTERISTICS
SKIN CIRCULATION
SKIN AND
SUBCUTANEOUS
TISSUE
SUPERSATURATION
VENOUS BLOOD
TO LUNOS
CAPILLARY BLOOD
FROM LUNGS
"Fig. 1. Dermal Lesion in Superficial Isobaric Counterdiffusion.
Schematic of circumstances In gas bubble formation without change
in ambient pressure. Excess inert gas saturation develops due to
more rapid flux of one gas, e.g., heliua, into the tissue and
capillary as a less rapidly moving second gas, e.g., nitrogen,
diffuses out to the atmosphere (4).
The Phenomenon of Isobaric Inert Gas Counterdiffusion
Counterdiffusion was first recognized and named as the cause of gas
lesion development in individuals who for a broad physiologic study (3)
were saturated in a helium atmosphere at constant pressure and who then
breathed neon-oxygen-helium and nitrogen-helium-oxygen mixtures at
pressures equivalent to AGO, 700, 900, 1200 fsw (3) (4) (5). These
individuals developed severe cutaneous itching, the first symptom of a
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larger problem that was partially solved by encompassing them in a gas-
tight suit into which they exhaled. Only regions of helium-exposed
skin, the scalp, hands, and skin of the face where the mask did not
cover, continued to itch (3). Cutaneous symptoms encountered in
previous experiments at a lower pressure were discounted as not
attributable to gas lesion development (6).
In the human subjects, continued exposure to ambient helium while
breathing a slower diffusing inert gas produced hard, raised, white,
bloodless, cutaneous lesions. It also produced severe vestibular
dysfunction (3) (4). What did the human studies tell us about where
bubbles form? Do they form in the local blood vessels or in tissue
spaces (Fig. 1)? The cutaneous lesions looked as though "bubbles" had
formed locally in tissue and forced out the blood. When these lesions
in man were dissected with a needle at the high chamber pressures, no
bleeding occurred. Venous gas embolism was not suspected.
DEPTH
lmt*1
1
2
3
4
7
10
EXPERIMENTAL CONDITIONS : Br"thln« /Chamber
«•»• / U»l
Ms/He
+
+
+
N./H.
•»•
+
+
+
+
+
Ar/Hs
+
+
+
+
+
+ .
N.O/IU
•»•
SF6/He
0
0
0
0
He/N.O
0
H«/Ar
0
Fig. 2. Exposures of Fig* to Superficial Isobarlo C»«
CounterdlCfuslon «C Aiiblene Pressures From 1 Co
10 ATA.
A (+) Indicates that lesions were observed, «n open circle (0)
that no lesions war* seen. The severity of lesions for any
given depth and tine was: H2<> > Ar > «2 * Ne (9).
After the observations in human subjects, the cutaneous gas lesions were
produced in pigs by having helium outside animals which breathed either
nitrogen, argon, or neon with oxygen (Fig. 2) (19)?. Gas spaces formed
not only in the most superficial layers of the skin, but also formed
throughout the skin thickness, and even in subcutaneous tissue spaces.
•The process also reached blood vessels and caused a continuous venous
gas embolism (9) (4) (2). In fact the gas spaces dissect the tissues as
gas lesions expand (Fig. 3) (4) (8). The lesions generate after an
initial time lag, and the process eventually leads to death from
continuous venous gas embolism (2), (9). Postmortem examination shows
that the vena cava is filled with gas bubbles (Fig. 4), and vessels of
deep tissues such as kidney, heart and retina may unexpectedly also
contain free gas (2), (9). Measurement of gas in an artificial
subcutaneous depot illustrated the pattern of deep subcutaneous gas
environment throughout the lethal process (Fig. 5) (23).
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"Superficial Isobaric Inert Gas Counterdiffusion."
The new lethal environmental hazard was christened "Superficial Isobaric
Inert Gas Counterdiffusion Gas Lesion Disease." It is'easily product
at one atmosphere without ever compressing or decompressing the
experimental animal. However, the appropriate gases must be used An
effective combination is nitrous oxide breathing while the animal'is
surrounded by helium (9).
Other structures besides the skin and venous circulation are involved
in isobaric Counterdiffusion. Vestibular dysfunction occurred early at
a stable pressure equivalent to 1200 feet of sea water in individuals
breathing a neon-helium-oxygen mixture while surrounded by helium In
one, nausea vomiting, and vertigo were so severe that he could not take
even fluids by mouth for several days. After about five days, recovery
allowed decompression (3). v-uvety
800 -
700 -
o>
1 600
w
v>
500
400
Ambient Pressure
Contro
Fig. 5. Changes In Cas Partial Pressures During Superficial
Isobaric Gas Counterdiffusion In Artificially Induced
Subcutaneous Gas Pockets (23). (Pig Breathing ^2/°-°2>
Surrounded by Helium).
What mechanism might produce such an unexpected and incapacitating
"vestibular" effect at constant ambient pressure? It occurred to us
that the round window membrane between the middle ear and inner ear was
functionally an external surface of the body, rather than an internal
structure, in spite of being located deep, internal to the thin tympanic
membrane (4). Helium might therefore at the very large ambient helium
partial pressure gradients experienced in 38 ATA experiments (nearly
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20,000 mm. Hg.), diffuse through the tympanic membrane, then through the
round window while the respired neon gas was escaping more slowly from
the endolymph into the middle ear (4). Helium passage through the
tympanic membrane of cats was measured, and found to be rapid (10) (11).
To learn whether isobaric counterdiffusion would produce bubbles in
endolymph we observed the round window by direct microscopy in guinea
pigs breathing nitrous oxide at one and at two atmospheres with helium
external to the round window (12). No bubbles appeared in the inner ear
fluid after several hours of this exposure. The specific cause of this
severe.and incapacitating isobaric gas lesion in man therefore still
remains an unsettled matter. It may relate to occurrence of as yet
undetected arterial gas emboli.
The absence of effects of superficial isobaric counterdiffusion on the
human eye is similarly unexplainable. Post-mortem photographs of the
retina through the lens of the eye after prolonged counterdiffusion of
pigs with nitrous oxide and helium at one ATA show gas bubbles deep, in
the retinal vessels. In the human subjects who generated skin lesions
there were never any symptoms, inflammation, or other evident effects of
the early counterdiffusion process on vision conjunctiva, sclera, or
cornea (4) (23) (13). When N20/He/2ata counterdiffusion was produced
through the surfaces of the eye in rabbits, no bubbles or lesions had
occurred by the time the exposure of the skin caused subcutaneous gas
lesions, venous emboli and death (13). The eye has a surface area of
the body where topical isobaric counterdiffusion occurs with no
detectable adverse consequences.
We have designated the isobaric passage of gas into the body through its
surfaces, and out of the body from capillaries through surfaces,
"Superficial Isobaric Inert Gas Counterdiffusion" (4). Reversal of the
counterdiffusing environmental and respiratory inert gases (e.g.
breathing helium-oxygen while surrounded by air or argon-oxygen) showed
that gas lesion'formation in subcutaneous tissues and venous gas bubble
emboli occur with the inward diffusion of helium and not with its
outward diffusion (9) (4). The fundamental concept of superficial
isobaric counterdiffusion gas phase development was analyzed
mathematically and studied with in vitro models, which showed that the
characteristics of gas diffusion through an aqueous/lipid interface
could determine whether or not gas phase separation would occur.
Different gases were made to diffuse in opposite directions through two
adjacent but different materials (water and olive oil) (5). Relative
diffusion rates for gases are determined by diffusivities and membrane
permeabilities, which together determine whether a gas "supersaturation"
would be large enough to cause bubbles to grow. Supersaturation was
predicted to be maximum when the square root of the product of the
diffusivities was equal to the ratio of the thicknesses of the membrane
(5).
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Fig. 6. Gas Partial Pressure Profiles Resulting From Steady
Counterdiffusion of Two Inert Gases.
The diagram on the left indicates concept of diffusion of two
different gases (1 and 2) across a dual barrier (layers A and B)
having different lipid-water compositions and, hence, different
permeabilities. The diagram on the right shows the gradients
resulting from this Counterdiffusion.
When the gases and barriers are so selected that the resistance
to transport is low in the first layer encountered and high in
the second, the sum of the gas partial pressures is shown
mathematically to be above the ambient pressure and is at a
maximum at the barrier interface (5).
Such events may be occurring in many millions of micro-loci
during a human exposure.
The potential for development of a very large degree of gas
supersaturation in exposed tissues is very great. At 1200 feet of
seawater (or 38 ATA where the phenomenon became recognized in man), it
should be theoretically possible to generate about 9 atmospheres of
supersaturation if the process is allowed to proceed to its maximum
extent (A) (5).
A specific and basic question is "What is the mechanism of origin of the
bubbles in supersaturated tissue and capillary which lead to lethal
venous gas embolism and destructive extravascular lesions at one ATA,
without compression or decompression or even movement?" Without
nucleation gas bubbles should not form, but bubbles do form. A
necessary explanation must therefore be that there are, inevitably and
continuously, pre-existing gas nuclei in normal tissue in life at one
ATA, Whether nuclei persist, or randomly form and regress, or both,
such nuclei would appear from the isobaric experiments to be
functionally very stable, since the Counterdiffusion syndrome occurs in
humans even after compression to 38 ATA. These empirical observations
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in animals and man must be kept part of any theoretical discussions of
roles of nucleation in diving and decompression.
The Superficial Isobaric Inert Gas Counterdiffusion phenomenon deserves
the designation as one of the "Gas Lesion Diseases" (4). In experiments
with pigs at sea level, the process of N20/He/l ATA superficial
counterdiffusion could cause death within an hour and a half when the
whole animal body was exposed to helium (9). To slow this rapid process
sufficiently in some experiments for detailed study, only the hind
quarters of other pigs were exposed (by enclosing them within a helium-
filled plastic bag). Removing the flow of gas emboli from the vena
cava with a bubble trap prevented them from reaching the lungs and
extended the life of the animal (14). This bubble trapping enabled
measurement of the volume rate at which gas emboli were generated by
counterdiffusion through a measured area of skin. It also allowed
detailed study of the local lesion development, from initial to severe
stages. With the animal breathing nitrous oxide and exposed to helium
over the lower body and nitrogen over the upper body, the N20/N2/1 ATA
counterdiffusion produced no visible effect, but the N20/He/l ATA
counterdiffusion formed cutaneous gas lesions and venous gas emboli,
disrupted skin capillaries, and had a grossly destructive effect on the
skin and subcutaneous sites. A very sharp line of visible demarcation
existed between the helium exposed region and the nitrogen exposed
region.
Venous gas embolism does not appear at once in such experiments (2).
There is a delay of approximately one half to one and one half hours
before gas emboli begin to accumulate in the bubble trap in the vena
cava, after which the rate of gas embolism becomes a stable process (2).
During this delay gas lesion development is occurring in the periphery.
At two atmospheres pressure, the volume rate of venous gas embolization
is the same as at 1 ATA (about 200ml/hr./sq.m) but the mass rate is
twice as great as at one atmosphere (14). The composition of the gas
emboli that collect in the vena cava bubble trap is mostly nitrous
oxide, some helium, along with a little nitrogen, oxygen, carbon
dioxide, and water vapor (2) (14). It is important to recognize that
the gas composition of venous emboli can not be considered to reflect
the process of counterdiffusion at the skin surface, since the venous
blood comes from many sources, superficial and deep.
This process of N2<VHe/l ATA Superficial Counterdiffusion can be used as
a controllable experimental tool to study early development of
peripheral gas lesions and the progression of any pathophysiologic
effects of gas emboli in the venous blood and "bombarding" the lungs.
The magnitude of effects on blood and lung can be experimentally
controlled by changing the skin surface area which is subjected to
counterdiffusion, or by changing the gas gradients, or by changing
ambient pressure. If the area is small enough, there will be no
increase in pulmonary artery pressure even though venous bubbles occur.
With larger skin areas the gas embolism causes a rise in pulmonary
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arterial pressure. In pigs which are monitored by venous and arterial
Doppler probes, no bubbles appear to cross the lungs despite constant
and continuous bombardment over six to eight hours. However, in one
animal with a patent septal defect, death occurred early and gas bubbles
were present in grossly visible amounts in arterial blood. It was only
when normal pigs were near death from severe venous gas embolism that
visible arterial eroboli were found (17). Undetectable gas emboli could
of course pass undetected, as suggested by the present of gas phase in
deep tissues in port mortem examinations.
Other pathophysiologic events occur prior to death. Peripheral vascular
resistance increases and the blood plasma volume decreases (17). We
have assumed these are effects of changes in capillary permeability and
injury to peripheral vessels through undefined chemical or physical
effects of peripheral gas lesions. No significant change in blood
coagulation factors occurred, however, even when the animals were nearly
dead. The eventual cause of death was respiratory failure with a
shocklike syndrome. The gas bubble emboli do not appear to damage the
pulmonary vascular endothelium even when steady state embolism is con-
tinuous for up to four hours (20). This differs from experiments using
continuous venous infusion of air, where lung damage does occur (19).
absolute ambient pressure
at 200 FSWG
total inert gas tissue tension
*P*50 FSWG
maximum _^^
 fcincrease ^^ \ helium tissue tension
480 N2 half-time<=*240 He half-time
nitrogen tissue tension
480 960 1440
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1920 2400
Fig. 7. Diagram of "deep tissue" isobaric supersaturation
caused by breathing helium after prolonged exposure
to N2-02 mixture. Total inert gas pressure rises,
and a composite supersaturation is maintained for
many hours in "slow-perfusing" tissues. The opposite
effect, an equivalent degree and time course of useful
subsaturation, is subsaturation, is expected with
breathing N2-02 after prolonged exposure to helium (4).
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"Deep Tissue Isobaric Counterdiffusion"
Inert gas counterdiffusion in another form can create supersaturation in
the deep tissues, even when the skin is underwater or not exposed to a
different inert gas. "Deep Tissue Isobaric Counterdiffusion" was
selected as the name to designate the supersaturation or subsaturation
which occurs when a diver "switches" from breathing one inert gas-oxygen
mixture to a different inert gas carrier for oxygen (4) (15). After
such a switch, from a "slower equilibrating" to a "faster equilibrating
" gas (e.g. from air to helium-oxygen) a slowly perfused tissue
saturated with nitrogen will become transiently supersaturated by entry
of the more rapidly exchanging helium. This deep-tissue supersaturation
continues for many hours, as predicted (A) and as D'Aoust demonstrated
by bubble detection in goats (15). The process has not been widely
encountered in man, but has been observed in helium exposures following
shallow nitrogen saturation (22). A long transient of venous gas emboli
can develop (7) (15), and it should for practical purposes of diving
safety be assumed until proven otherwise that gas lesions generated by
decompression in poorly perfused tissues will be expanded by "deep
tissue isobaric counterdiffusion" (2). It is for this reason that
helium should not be substituted for air breathing in treatment of
severe decompression sickness resulting from air diving, without the
degree of concurrent compression calculated to assure marked immediate
reduction of bubble volume (as in Treatment Table 7A (18).
The reverse principle can produce a beneficial "subsaturation," however,
as Keller and Buehlmann proposed when they employed switch from faster
to slower diffusing inert gases (e.g., helium to nitrogen) to accelerate
overall inert gas elimination during decompression (16). Deep tissue
isobaric inert gas counterdiffusion subsaturation is now used to
advantage in several commercial and laboratory decompression procedures,
as well as evolving military diving methods.
SUPERFICIAL
IC COUNTEMDirrUSION
(CONTINUOUS I
DEEP TISSUE
tsotifttc couNTcnoirrusiON
I TRANSIENT)
DECOMPRESSION
Fig. 8. Interactions among gas phase decompression, compression
and isobaric states in several forms of gas lesion (2) .
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Interactions of Counterdiffusion Processes. Oxygen and Decompression
The concepts and empirical observations elaborated above illustrate that
several types of gas lesion diseases are associated with diving, and can
co-exist in two or more forms (1) (2). Decompression must necessarily
exaggerate the effects of isobaric gas lesions, and isobaric
supersaturations should also be conceived as necessarily exaggerating
decompression incidents and the problems of decompression sickness
therapy. In all, the informed use of increased oxygen pressures offers
a means of prevention as well as a means of therapy. (1). For the
counterdiffusion diseases, absolute prevention of each is now possible
through proper choice of respiratory and ambient gases or gas
sequencing. Practical precautions recommended early to prevent or
minimize adverse interactions include (2):
0
 Avoidance of mask breathing of air or N2-C>2 while body surface or the
ear canals are exposed to helium.
° Avoidance of an abrupt change from air or N2-02 breathing to helium-
oxygen at a constant or decreasing pressure.
° When it is clearly desirable during therapy for severe decompression
sickness to proceed from air or N2-02 breathing to prolonged exposure at
a higher ambient pressure than is sensible for nitrogen, compression on
helium is recommended despite the potential hazard of deep-tissue
counterdiffusion supersaturation (18). Such change to helium should be
accompanied by prompt compression and appropriate oxygen pressure, to
counter the tendency for bubble growth or development.
° Switch from prolonged helium breathing to air or N2-02 breathing to
achieve deep counterdiffusion subsaturation is a desireable aid to
prevention of decompression sickness in helium diving. In a pressure
chamber it should occur by a change in ambient atmosphere rather than by
mask breathing, to avoid superficial counterdiffusion. The transition
should take place gradually, rather than abruptly, to avoid exaggerated
sensations of narcosis which may be confused with vestibular effect.
° Use of increased oxygen in inert gas - oxygen mixtures remains the
most effective means to reduce tissue total inert gas pressure in the
prevention and therapy of each form of gas lesion disease. In
conjunction with deep isobaric counterdiffusion sub-saturation the
limitations are those of tolerance to oxygen.
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CARDIOVASCULAR AND RESPIRATORY RESPONSES TO PROLONGED
ISOBARIC INERT GAS COUNTERDIFFUSION GAS EMBOLISM IN PIGS
Abstract
Anesthetized pigs were artificially ventilated with N£>-02 while areas
of body surface were exposed to helium at 1 ATA. Venous gas embolism
generated by isobaric counterdiffusion (N^ D/He/1 ATA) was detected at a mean
of 83 + 23 min., by a doppler cuff placed around the inferior vena cava, and
persisted until death or termination of the experiment. When only the
hindlimbs of the animal were exposed to He (n=4), no change in baseline
physiologic parameters occurred up to 18 hours despite the development of vena
gas caval embolism. When the exposed skin area was increased to include trunk
and extremities (n=9), pulmonary arterial hypertension occurred, without
increase in pulmonary artery wedge pressures, but with progressive
tachycardia, late systemic hypotension and decrease of cardiac output during
the period of continued embolism. Sequential venous blood measurements
demonstrated progressive hemoconcentration, no change in the normalized values
of white cells, and a decrease in platelets. Sequential arterial blood gas
determinations showed progressive hypoxemia, hypercapnia and acidosis.
Survival ranged from 5.4 to 28.0 hours. At autopsy, all animals demonstrated
large amounts of gas bubbles in the venous side of the circulation while 2
animals also demonstrated left ventricular and arterial free gas. In 5
additional animals, bronchoalveolar lavage material obtained at baseline and
after 1 and 4 hours of embolism demonstrated no significant change in protein
content or number or distribution of cells. In these animals, lung wet to dry
weight ratios indicated no lung edema accumulation, and light microscopic
2
examination of post mortem lung tissue indicated preservation of the lung
microstructure. Physiologic events observed during these lethal isobaric
venous gas embolism exposures in pigs depended on the amount of skin exposed
to the external gas. The isobaric phenomena resemble those in decompression
sickness, with the important exception of the occurrence of pulmonary edema in
severe pulmonary decompression sickness.
isobaric; inert gas; counterdiffusion; isobaric counterdiffusion; venous gas
embolism; decompression sickness; gas embolism.
INTRODUCTION
Breathing an inert gas while surrounded by another of faster diffusive
properties has been found in both man and animals to produce free gas in
tissues, and venous gas emboli, without a change in environmental pressure
(19). The process leading to the pathologic effects was named "Superficial
Isobaric Counterdiffusion Gas Lesion Disease" by its discoverers (19). Its
occurrence and severity has been shown to depend on the particular combination
of respired and environmental gas as well as the environmental pressure (15).
Its theoretical bases have been described (12)(16)(18)(19)(20)(21).
Initially identified in man, counterdiffusion supersaturation was found
to produce severe itching, gas-filled dermal lesions, and vestibular
•derangement (19) (19a). In animals, prolongation of the process produces gas
embolism and death (19a)(20)(28). Systematic analysis of different gas
combinations and animal models has identified the young pig breathing N£>
while surrounded by helium as a useful experimental method for investigation
of the effects of isobaric gas embolism at 1 ATA (15)(20). In this situation,
gas bubbles develop in peripheral tissues and blood, ultimately resulting in
death of the animal in few hours (19a)(20). After a latency period, the
volume rate of isobaric venous gas embolism becomes nearly constant, is
independent of the environmental pressure, and can be readily decreased by
reduction of the inspired inert gas partial pressure (19a)(21). This
experimental production of stable rates of isobaric gas embolism has provided
a unique experimental model for systematic, dose-effect study of endogenously
generated gas embolism in intact animals. It has special importance in
relation to the pathophysiology of decompression sicknesses and other dysbaric
disorders, since the development of a gas phase in peripheral tissues and
blood is a fundamental part of decompression pathophysiology (9)(19a).
Isobaric counterdiffusion provides an alternative to production of bubbles by
decompression, which is transient and unpredictable in amounts, or to
intravenous infusion of gas bubbles, which ignores the contribution of gas
lesion phenomena occurring in peripheral tissues. The purpose of the work
presented in this paper was the analysis of circulatory and pulmonary effects
during continuous N£)/He isobaric counterdiffusion gas embolism leading to
death.
METHODS
Animal Preparation
A total of 23 Yorkshire pigs of both sexes (20-30 kg) was utilized for
the study. Animals were anesthetized with pentobarbital sodium (30-50 rag/kg
i.p.) and placed in a prone position. Polyethylene catheters were placed into
the left external jugular vein and common carotid artery, for administration
of fluids to compensate for blood drawing and dermal and respiratory fluid
losses, and for continuous recording of systemic arterial pressure. Adequate
level of anesthesia was maintained with pentobarbital 5-10 mg/kg/hr
intravenously, with additional intermittent administration to suppress
spontaneous ventilation. A tracheal cannula was inserted through a cervical
midline incision and the animal connected to a volume respirator. Ventilation
gas was N^-02 79/21%. Tidal volume and respiratory rate were adjusted to
keep PCC>2 within 36-40 torr. Ventilator settings were then held constant
throughout the experiment. Sighing was accomplished during the experiment
every 20 minutes with twice the tidal volume. An 8-French Swan Ganz
thermodilution catheter was advanced through the right jugular vein to a
branch of the pulmonary artery, guided by pressure contour. This allowed for
continuous recording of pulmonary artery pressure and intermittent
determination of thermodilution cardiac output (Edwards model 9510 A). Heart
rate was derived from a continuously recorded lead II of the
electrocardiogram. A Doppler bubble detector cuff (Parks Electronics Lab,
Beaverton, Ore.) was then placed around the inferior vena cava through a
lateral abdominal incision without entering the peritoneum. Doppler signals
were analyzed in a model 1040 ultrasonic flowmeter (Sound Products: Institute
for Applied Physiology and Medicine, Seattle, Washington), and displayed on an
oscilloscope with audio output continuously monitored and recorded on magnetic
tape. A thermal probe was utilized for continuous recording of rectal
temperature, which was maintained between 1 c of initial baseline by
intermittent use of a thermal blanket. The complete surgical procedure took
approximately 30 minutes and blood loss was less than 25 ml.
Generation of Isobaric Counterdiffusion Gas Exchange
In all animals nitrous oxide with 21% oxygen was respired for 1 to 2
hours prior to exposing skin surface to helium. This control situation, used
as a baseline, represented Np/Air/l ATA counterdiffusion, a situation in
which prior investigations have demonstrated no cutaneous gas lesions. In
four early experiments, a plastic bag was placed around the hind limbs of the
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animal and filled with helium, initiating the N^D/He counterdiffusion process,
as in a prior study (19a)(21). Since this limited body surface area for
counterdiffusion did not produce definitive changes in measured physiologic
parameters, the amount of exposed skin was increased to include the trunk and
extremities in 9 additional animals. All data presented in this paper were
obtained with this larger area of counterdiffusion, with only the head and
neck exposed to air. In 5 control experiments, helium was not used and
control measurements were performed repetitively for 12 hours.
Blood Sampling - Analytical Methods
During the baseline period and intermittently during the period of
counterdiffusion, blood samples were collected via the jugular catheter for
hematologic studies that included hemoglobin, hematocrit, white cell and
platelet count by automated procedures with a cell track 560 (Angel
Engineering, Nova, CT). Values were normalized based on changes in hemoglobin
concentration. Blood gases were determined sequentially with a Corning 165/2
analyzer calibrated with radiometer precision buffers and laboratory validated
gas mixtures. Measured blood values were corrected to rectal temperature. In
5 additional animals, bronchoalveolar lavage (BAL) material was obtained at
baseline and after 1 and 4 hours of embolism, by infusion of 100 ml of normal
saline in aliquots of 20 ml through a fiberoptic bronchoscope wedged in an
appropriate position. Fluid aspirated following infusion was filtered through
sterile gauze and was used for analysis of total protein and albumin content,
as well as for total and differential cell counts.
After the death of the animal in the experimental counterdiffusion series
and after 12 hours in the control experiments, the thoracic and abdominal
cavities were opened and internal organs inspected for the presence and
distribution of gas bubbles. Heart chambers and great vessels were opened.
In 4 experimental animals, the left lung was taken out of the thorax and fixed
overnight at 25 cm water pressure with buffered formalin. Sections were
evaluated by light microscopy after hematoxylin and eosin staining. In 6
experimental animals and in 3 controls lung wet to dry weight ratios were
obtained in the right lung.
Results
Cardiovascular, blood composition and blood gas values remained
essentially at baseline levels in the control experiments evaluated for 12
hours using the N^ /Air/l ATA condition. Definite pathophysiologic effects
occurred when NjO/He/l ATA counterdif fusion was produced. (Table 1, and
Figures 1-8 in Final Report)
Dermal Changes and Survival. When only the hind limbs were exposed to helium,
dermal lesions on the counterdiffused skin followed by vena caval embolism
occurred as previously reported (21). However, no significant change from
baseline levels of systemic or pulmonary arterial blood pressures occurred
during exposure up to 18 hours. When the area of exposed skin was increased
to involve trunk and extremities, the gas lesions of superficial
counterdiffusion, beginning as flat erythematous blotches, appeared on the
surface of the skin within 30 minutes of beginning exposure to helium, and
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evolved in size and numbers to include the white, raised lesions previously
described (20). Doppler signals of vena caval gas embolism developed at 1.5 +
0.2 hours (mean+ s.e.) (range 0.6 - 2.4) after the beginning of helium
counterdiffusion exposure and persisted to the end of the experiment. In one
animal, death occurred following the sudden development of systemic
hypertension only 30 minutes after beginning helium flow into
"counterdiffusion bag" surrounding the body. As the presence of a patent
atrial septal defect was demonstrated at autopsy, this animal has not been
included in the overall analysis which follows. Survival time of the other 8
animals was 10.3 + 2.6 hours (range 5.4 - 28.0).
Circulatory Effects. No significant changes occurred prior to venous gas
embolism. With the onset of intravascular bubbles, mean pulmonary artery
pressure rose from a 17.3 + 3.2 mm Hg control value to 28.4 + 4.2 mm Hg and
remained elevated until a circulatory failure associated with death.
Pulmonary capillary wedge pressures remained at control levels or decreased
slightly throughout the experiment. During the period of venous gas embolism,
a progressive increase in heart rate was observed up to the time of death,
associated with a decrease in cardiac output. Concurrently, a steady rise in
hemoglobin concentration and hematocrit occurred, and a decrease in platelet
count, while no significant changes occurred in the total white cell count
(both normalized to initial hemoglobin concentration) (Fig. 4, 5). In 6 of
the 8 animals, systemic arterial hypotension developed 1 to 2 hours prior to
death. In 3 of these animals, infusion of 200 ml or normal saline over 10
minutes during the period of hypotension restored arterial blood pressure to
normal levels. Discontinuation of the infusion resulted in return of
hypotension, and death. Two animals died rapidly without previous, changes in
systemic arterial pressure.
Arterial Blood Gases and pH. Blood gas and pH determinations during the
period of counterdiffusion demonstrated progressive arterial hypoxemia,
increase of PCC>2 and acidosis, in spite of constant volume artificial
ventilation.
Broncho-Alveolar Lavage (BAD. Protein and albumin content, as well as
differential and total blood cell counts in material collected during
embolism, were not different from control values.
Necropsy. At necropsy, as in previous studies (19a)(20)(28), large amounts of
free gas were noted in the venous side of most vascular beds, and in 2 animals
gas bubbles were also seen in the left ventricle and coronary and systemic
arteries. Measurements of lung wet to dry weight ratios of experimental
animals' were 6.1 + 0.4, not different than control values, and light
microscopic examination of pulmonary tissue did not demonstrate abnormalities.
Specifically, no perivascular cuffing or intra-alveolar material was found.
Discussion
Research following the discovery of the pathologic and lethal
consequences of isobaric inert gas counterdiffusion gas lesion disease has
demonstrated that as a result of this process, the characteristic continuous
venous gas embolism may be accompanied by gas bubbles distributed extensively
in tissues of multiple organs and systems (20). Our present experiments
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determined the sequence of physiologic changes from the development of severe
counterdiffusion venous gas embolism, to the death of the experimental animal.
The results indicate that from initial gas embolism to death, multiple
physiologic changes occur, and include derangements in blood composition,
hemodynamics and gas exchange function.
A previous investigation, utilizing a venous gas embolism trap, has
demonstrated that, once established, counterdiffusion venous gas embolism
progresses at a stable rate (19a)(21). Thus, effects noted in the present
experiments are considered to have been produced by a nearly constant "degree"
of embolic stress. It was not possible in these experiments to both allow
venous gas emboli to bombard the cardio/pulmonary/hematologic system and to
trap the emboli for volume rate measurement. Although it is recognized that
Doppler techniques do not provide a good quantitative measure of "embolic
volume dose", the intensity of the signal indicating bubble frequency was
noted to remain remarkably stable throughout the experiment. In addition, the
stability of elevated pulmonary artery pressures throughout the embolic period
suggest a constant embolic dose, since rate of venous gas embolism and degree
of pulmonary hypertension have been elsewhere shown to be linearly correlated
(7). When only hind limbs were exposed to helium, prolonged survival for up
to 18 hours without significant variation in pulmonary artery and systemic
artery pressures indicates that the lethal pathophysiological response to
isobaric gas embolism increases with the amount of exposed gas. This capacity
for controlling the rate of stable gas embolism in the superficial isobaric
counterdiffusion model can be utilized in experiments requiring prolonged
sublethal exposures such as in the study of late hematologic effects of
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decompression from hyperbaric exposures (25).
Overall responses encountered during our experiments, including
pulmonary arterial hypertension, systemic arterial hypotension,
hemoconcentration, and arterial hypoxemia resemble previous findings in severe
decompression-related gas lesion diseases in man and animals (8)(24).
Sustained pulmonary arterial hypertension has been previously reported
repeatedly in association with gas embolism in circumstances like
decompression sickness, experimental intravenous infusion of gas bubbles, and
iatrogenic gas embolism (24)(13)(29). In addition to the obvious effect of
obstruction of pulmonary vascular channels by bubbles, there is evidence from
other models of venous gas embolism that humoral (17) and reflex (29)
mechanisms may participate in the pathogenesis of the pulmonary arterial
hypertension. Active vasoconstriction of pulmonary vascular beds not
obstructed by bubbles has been suggested as a "protective mechanism" against
development of pulmonary edema (13). The stability of pulmonary capillary
pressures observed during counterdiffusion embolism in the present experiments
essentially eliminates left heart failure as a contributory mechanism for the
pulmonary hypertension. This is consistent with previous observations in
other gas embolism syndromes (27) (2). Although the pulmonary hypertension
induced by the effects of counterdiffusion venous gas embolism is comparable
in degree to that produced by other experimental and clinical situations where
definite lung injury occurs (15) (23) (1), our data concerning lung wet to dry
weight measurements, analysis of BAL material, and lung light microscopic
examination does not indicate that pulmonary edema was a prominent consequence
of even lethal isobaric embolism. If present, lung injury produced by sub-
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lethal isobaric counterdiffusion is mild, and any increases in lung
microvascular permeability such as found in other models of gas embolism may
be resolved by way of the pulmonary lymphatic drainage, limiting accumulation
in the lung interstitium. Differences with effects on lung fluid balance
noted previously with decompression or infusion of air bubbles (1)(8)(27) may
relate to any of several factors including specific dimensional properties of
bubbles, the background state and entity of inert gas saturation, and possibly
reasons related to species differences in pulmonary response to gas embolism.
The observed impairment of pulmonary-arterial oxygen and carbon dioxide
gas exchange function during the period of venous gas embolism is consistent
with what has been observed previously by other investigators using different
methods (8) (13). Such previous analysis in the dog has indicated that acute
oxygen and carbon dioxide exchange impairment in gas infusion embolism is
independent of the gas composition of the bubble; hypoxemia appears to be
caused primarily by ventilation/perfusion mismatch rather than shunt (perhaps
aggravated by decreases in cardiac output observed during our experiments),
and increases in arterial PCC>2 relate to increments of physiologic dead space
by addition of high ventilation/perfusion areas (13). In the present
experiments with isobaric counterdiffusion, respiratory gas exchange
alterations alone were insufficient to cause death. However, hypoxia may have
been a contributory factor in damage of tissues with circulatory patterns
altered by local gas lesions, and in the passage of venous gas emboli to the
arterial side of the circulation (26).
A significant finding in these experiments relates to the presence of
13
widespread gas in the arterial blood of two animals in the series reported
here. Although autopsy was performed immediately after the death of the
animal, it is conceivable that some growth of the bubbles occurred even during
that short period (19a). If this is the case, circulating bubbles before
death may have been less in total volume. In any case, it is clear that at
least some embolism must have occurred to the arterial side of the circulation
and possibly for some time before death. The occasional transient arterial
hypertension observed in these two animals during the isobaric embolic period
may have been related to this phenomenon. The two animals that had arterial
bubbles at autopsy had no grossly evident anatomical shunts. Neither did they
demonstrate the profound cardiovascular changes commonly associated with
arterial embolism (10), or differences in survival duration, or unusual
cardiorespiratory phenomenon before death, compared to the rest of the
animals. The passage of gas bubbles from the venous to the arterial
circulation of dogs has been found to be -dependent on the volume rate of
embolism (5), and the size of the bubble (7). In our experiments, the
transpulmonary passage of such emboli may have been caused by incomplete
release of gas during alveolar transit, with small bubbles reaching the
pulmonary veins and growing in the arterial circulation in the presence of
saturated blood (19a). Another possibility relates to the opening of
pulmonary vascular shunts during embolism. Such mechanisms of transpulmonary
embolism have been documented and found to be aggravated by hypoxia (26),
aminophylline (5) and oxygen toxicity (6). All are potential components of
the pathology and treatment of the gas lesion diseases.
Determination of the conditions that produce and/or aggravate the
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passage of undissolved gas from the venous to the arterial circulation is of
critical importance in prevention of the dysbaric disorders. The
counterdiffusion model provides a means of systematic investigation of this
particular phenomenon.
The progressive hemoconcentration observed during our experiments has
been a common finding in other situation where gas embolism exists. It has
been interpreted as indicating a reduction in plasma volume as a result of
increased microvascular permeability (2)(4). This effect has been observed in
intact animals after rapid decompression (2), as well as in isolated venous
and arterial strips (22). In the present study, the combined hemodynamic
response of progressive tachycardia, decreased cardiac output and late
hypotension is consistent with the development of progressive hypovolemia. In
addition, during the period of hypotension it was possible to restore normal
levels of systemic pressures with infusion of normal saline. Microvascular
permeability increase was not found in the lung in these studies, at least as
could be indicated by wet/dry weight ratios and light microscopy. This
apparent paradox of venous gas embolism could relate to the fact that during
counterdiffusion, persistent gas separation occurs in peripheral tissues (20)
which could trigger and sustain the release of local inflammatory mediators
with the capacity of amplification of this effect (19a). Bubbles could not be
demonstrated in lung parenchyma during extensive studies of tissue
distribution of counterdiffusion bubbles (20). The observed decrease in
platelet counts during the late phase of isobaric embolism, previously
observed in association to decompression-related phenomena (25) , indicates
that these cells participate in the effects of counterdiffusion gas embolic
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processes.
In conclusion, the present experiments demonstrated the occurrence of
changes in blood composition, circulation and respiration during continuous
venous gas embolism generated by lethal isobaric counterdiffusion.
Abnormalities in pulmonary gas exchange appear due to functional rather than
structural disruption. In addition, it was found that during severe
counterdiffusion, when critical conditions develop, bubbles can reach the left
side of the circulation even without an abnormal anatomical shunt, and may
possibly be tolerated for a period of time, then constitute one of the
potential mechanisms of death in counterdiffusion embolism. The hemodynamic
response of progressive tachycardia, decrease in cardiac output and late
arterial hypotension associated with progressive hemoconcentration strongly
suggest the development of peripheral systemic microvascular plasma loss
resulting in lethal hypovolemia. Isobaric counterdiffusion has provided a
method for systematic investigation of biological effects of endogenously
generated gas embolism in gas lesion diseases. Characterization of the basic
mechanisms operative in this complex group of diseases will provide a rational
basis for improving upon present techniques of prevention and therapy.
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TABLE 1 (Appendix B)
HEMODYNAMIC, BLOOD GAS AND HEMATOLOGIC RESPONSE
TO SUPERFICIAL ISOBARIC COUNTERDIFFUSION VENOUS GAS EMBOLISM
.Observation Animals
HR
PAP
PVR
SP
CO
P02
pco2
pH
HGB
HCT
WBC
NEUT.
PLAT
Beats/m
mm Hg
cm H20/L/m
mm Hg
L/m
mm Hg
mm Hg
gm/dl
%
x 103/ml
%WCB
x I03/ml
6
6
6
6
5
5
5
5
5
5
5
5
5
Baseline
148.3 ± 5
17.4 + 1.4
4.5
105.8 ± 2.0
4.52 ± 0.73
87.5 ± 0.5
38.1 ± 1.2
7.48 ± 0.02
.11.1 ± 0.7
34.1 ± 1.1
19.6 ± 2.9
43.6 ± 7.4
576 + 94
Counterdiffusion
2.4 Hours
186 ± 10*
33.1 ±4.5*
10.8
105.1 + 2.3
3.82 ± 0.74
56.1 +4.0*
44.3 ± 2.8
7.39 ± 0.04
12.1 ± 0.4
36.6 ± 2.1
23.2 ± 5.2
59.0 ± 10.2
508 + 67
5.2 Hours
214 ± 16*
32.9 ± 4.4*
15.0
102.2 ±3.3
2.83 ± 0.4*
47.4 ± 5.0*
52.4 ± 6.0*
7.3 ± 0.08*
12.7 ± 1.1*
39.2 ± 0.9*
20.7 ± 4.1
61.4 ± 12*
436 + 97*
HR - Heart Rate; PAP - Pulmonary Artery Pressure; PVR - Pulmonary Vascular Resistance; SP -
Systolic Pressure; CO - Cardiac Output; P0? - arterial partial pressure of oxygen; PCO-
arterial partial pressure of CO,; HGB - Hemoglobin; HCT - Hematocrit; WBC - White Blood Cell
Count; Neutrophils; Plat - Platelet Count.
* = significant change from Baseline (p <.05)
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Abstract
Experiments were performed to study the effect of isobaric counterdiffusion
venous gas embolism on the blood contact system and coagulation.
Counterdiffusion venous gas embolism was generated by helium exposure of trunk
and extremities of 6 anesthetized instrumented pigs artificially ventilated with
Np/02 at 1 ATA. Extensive dermal changes, pulmonary artery hypertension,
tachycardia, decrease in cardiac output, arterial hypoxemia, and
hemoconcentration occurred during the embolic period in all animals. Values of
PT, PTT, Plasma Fibrinogen concentration, and functional activities of factors
XII, XI, Pk (prekallikrein) and HMWK ( High Molecular Weight Kininogen) did not
significantly change from baseline values after 1 and 4 hours of continuous
embolism. In 2 of these animals, samples collected after 6 hours of embolism
during systemic hypotension preceding death, also demonstrated no changes in
these parameters. We concluded that lethal pathophysiologic phenomena occurring
during isobaric counterdiffusion gas embolism are not dependent upon activation
of the blood contact system and coagulation.
Gas embolism; decompression sickness; contact system; coagulation; bubble-
blood interaction; isobaric counterdiffusion; diving; aerospace.
Introduction
The presence of gas bubbles in tissues and blood of man and animals is
known to produce pathological manifestations in a variety of clinical,
operational and experimental situations (1)(18)(34). In addition, gas "bubble"
surfaces are thought to play a central role in the generation of decompression
sickness, a pathological state of varied symtomatology associated with reduction
of environmental pressure during undersea and aerospace operations (6)(7)(19).
In addition to causing obstruction of vascular channels, it is considered
that part of the pathogenesis of gas lesion diseases relates to the biological
responses elicited by gas bubbles in-peripheral tissues and blood (10)(5).
Platelet and neutrophil aggregation (2), endothelial damage (32), complement
activation (40) and occurrence of a beneficial therapeutic response to anti-
inflammatory agents (8) are some of. the observations that support this notion.
Knowledge of the pathways of activation of such responses is of importance for
the development of methods of prevention and therapy of gas lesion diseases.
However, the initiating events and the specific biological defense systems
participating in the development of these responses have not as yet been
identified. Possible initiating factors include release of mediators by
mechanical injury of tissues, stimulation of cellular components of blood, and
activation of humoral circulating systems by bubbles themselves or bubble
mediated tissue structural damage.
One of the systems that has been postulated as an active participant in
the initial phase of the pathogenesis of dysbaric disorders is the blood contact
system (13) . This group of proteolytic enzymes initiates surface activation of
coagulation, fibrinolysis complement and kinin formation and has been found to
participate in many human inflammatory and immunologic diseases including
arthritis (23), transfusion reactions (3), renal allograft rejection (14) and
thyroid and rocky mountain spotted fevers (15)(42) and nephritic syndrome (29).
The participation of the contact system in the pathogenesis of gas lesion
diseases has been suggested by in vitro (24) and in vivo (25) experiments as well
as observations in man and animals consistent with consumption coagulopathy in
severe cases of decompression sickness (35)(5). However, and in vivo detailed
analysis of this system during the initial period of endogenously generated
venous gas embolism is not available. The pig isobaric counterdiffusion gas
exchange model (36) provides an excellent opportunity to perform this type of
experiment, since it provides a stable amount of tissue-generated gas embolism
associated with physiologic changes typical of gas lesion disease (26)(37). Of
additional importance is that the pig contact system resembles the human (41).
This paper presents the results of experiments designed to study the
participation of the contact and coagulation systems in the pathophysiologic
responses to prolonged, continuous isobaric counterdiffusion venous gas embolism
in pigs.
Methods
Animal preparation. This preparation has been described previously in
detail (26)(36). Briefly, Yorkshire pigs (25-35 kg) anesthetized with
pentobarbital were instrumented with vascular catheters for continuous recording
of common carotid artery pressures and a left external jugular vein line for
administration of fluids and blood sampling. Artificial ventilation was
accomplished with N 2°/°2 (79%/21%) with a tidal volume of 15 ml/kg. The
respiratory rate was initially adjusted to produce a PC02 of 36-40 torr and this
setting was held constant throughout the experiment. An 8 French Swan Ganz
catheter was advanced through the right jugular vein guided by pressure contour
into the pulmonary artery or one of its branches for continuous recording of
pulmonary artery pressures and intermittent determination of cardiac output
(Edwards model 9510A). To initiate the counterdiffusion process, a plastic bag
was placed around the trunk and extremities and filled with flowing helium. In
3 control experiments, helium was omitted and measurement followed for 8 hours.
Experimental protocol. The time of development of venous gas embolism
(about 80 minutes from beginning helium flow) was considered the initiation of
pulmonary hypertension, as a close correlation of these parameters has been
previously observed a close correlation of these parameters (36) . At baseline
and after 1 and 4 hours of embolism, blood samples were collected from the
jugular vein catheter for hematologic studies that included hemoglobin,
hematocrit, white cell and differential and platelet count by automated
procedures with a cell track 560 (Angel; Engineering, Nova, CT) . Values of
white cell and platelet concentrations were normalized to baseline hemoglobin.
Simultaneously, arterial blood gases were determined with a Corning 165/2
analyzer calibrated with radiometer precision buffers and analyzed gas mixtures.
Measured values were corrected to rectal temperature.
Functional activity of contact factors (activated partial thromboplastin
time, (aPTT) , prothrombin time (PT) and fibrinogen concentration) was determined
in venous samples in all animals and values normalized by the method of Dill
(17). In addition, for the purpose of comparison, in 2 animals simultaneous
arterial samples were obtained for measurement of blood cell counts and contact
factor activity.
In 2 of the animals in this overall group it was possible to collect
additional samples after 6 hours of continuous gas embolism, at which time
preterminal systemic hypotension was present.
Hemodynamic parameters were followed in all animals until death occurred.
Immediately following (within two minutes), and autopsy was begun that included
inspection of all major organs, and presence of bubbles in vascular beds.
Analytical methods. For determination of activity of contact factors and
coagulation times, 4.5 ml of blood were collected in 0.5 ml of 3.8% sodium
citrate-O.lM e-aminocaproic acid. Samples were spun at 10,000 g for 15 min. in
a refrigerated centrifuge, divided in 0.3 ml aliquots and stored at -70*'until
processing. Only polypropylene materials were utilized for collection and
handling of samples. Samples for Pk (Prekallikrein) determination were processed
at room temperature before being stored in a deep freezer, as there is indication
that cold is capable of activating this protein. The aPTT, FT and fibrinogen
concentration were determined according to standard methods (12)(8)(38).
Functional assays of factors XII, XI, and High Molecular Weight Kininogen (HMWK)
were measured with a modified aPTT utilizing factor deficient human plasma. PK
activity was measured with a chromogenic assay (16).
Results
Control experiments showed no alteration in hemodynamics, hematologic or
blood gas values followed during 8 hours. In the experimental animals, as
previously described, (26) erythematous lesions appeared on the surface of the
skin within 30 minutes of the beginning of counterdiffusion, followed by gas
filled lesions mainly on the skin of abdomen, thorax and outer aspects of the
limbs. After an average of 85 minutes, mean pulmonary artery pressures increased
from a baseline of 17.4 +/- 2.0mm.Hg. to33.0+/- 4.55 (mean +/- s.e.) signaling
the initiation of venous gas embolism (36) . Pulmonary artery hypertension
persisted at an elevated level until death of the animal, associated with
progressive tachycardia and a decrease in cardiac output, while systemic arterial
pressures remained close to control levels almost to death during the period of
embolism in 4 animals but decreased by the 6th hour and until death in 2 animals.
Details of cardiovascular and respiratory changes, and findings at necropsy are
described in a parallel paper (37).
Hemoglobin concentration and hematocrit increased significantly at 1 and
4 hours. Based on these data, reductions in plasma volume of 15% and 26%
respectively were calculated by the method of Dill (17) , and utilized to
normalize information concerning coagulation factors. White cell counts did
not change significantly from baseline levels for all animals at 1 and 4 hours,
or in the 2 animals studied for 6 hours. Platelet counts decreased with prolonged
exposure.
Significant alterations did not occur in the normalized values of aPTT,
FT, fibrinogen levels or functional activity of factors XII, XI, PK and Hmwk
obtained at 1 and 4 hours of counterdiffusion embolism.
Discussion
Many of the clinical manifestations of gas lesion diseases in man and
animals suggest the participation of inflammatory processes in the development
of pathophysiologic effects (5)(10). In addition, intact animal experiments
have demonstrated the capacity of gas bubbles to effect tissue injury through
mechanisms ancillary to direct physical trauma or vascular blockage. Selective
depletion of cell populations (20) and inhibition of specific mediators
(21)(22)(28) have been shown to modulate local pathophysiologic effects of gas
bubbles, and thus suggested their participation in the pathologic process.
However, the nature, precise sequence of generation and relative importance of
inflammatory species in dysbaric disorders are not known.
The participation of the contact system in the initial steps of the
pathogenesis of gas embolic disorders, resulting in the development of a harmful
response, has been postulated based on in vitro and in vivo observations
(24)(31)(27). Denaturation of plasma proteins on the surface of gas bubbles
demonstrated by Lee (30), provides the potential substrate for activation of
factor XII, the first step in the chain of events leading to activation of the
coagulation, complement and kinin formation systems. . In addition, an
intermediate product of this activation factor Xlla, has been shown to have the
ability to activate neutrophils (39), which may explain the aggregation of
platelets and neutrophils observed frequently on the bubble surface (2) (32).
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In addition, plasma of dogs and selective populations of rabbits in contact with
gas bubbles demonstrate activation of the coagulation (24) and complement (40)
systems respectively, processes potentially mediated by the contact system.
Further support for the notion of .surface activation of biological defense
systems by bubbles is provided by documentation of coagulation abnormalities in
severe cases of decompression sickness in divers (5) and experimental animals
(35).
However, our experiments failed to detect a significant activation of
these systems which is usually manifested by a decrease in coagulation 34 mm
gas, after a prolonged period of tissue-generated venous gas embolism associated
with dermal and subcutaneous tissue disruption, hemodynamic changes, hypoxemia
and hemoconcentration. It is therefore unlikely that in our experimental
situation, isobaric counterdiffusion venous gas embolism, the blood contact
system is responsible for the initiation of the processes leading to these gross
pathophysiologic effects which actually occurred in prolonged exposures. Direct
stimulation of leukocytes and platelets and activation of humoral systems
independent of the contact system remain as possible alternative mechanisms.
The present experiments were purposely limited to the embolic early (one
to four hour) period associated with hemodynamic stability, and avoided the near
death period with its profound changes in multiple physiological parameters.
These gross effects would have made interpretation of positive changes in the
contact system difficult. However, analysis of blood samples collected in 2
animals during the hypotensive period that preceded death also demonstrated no
activation of contact factors even at this advanced stage of the lethal gas
embolism. This supports the concept that hypotension was generated in this
situation through mechanisms independent of increased generation of bradykinin
in the superficial sites of gas lesion development.
The present results are comparable to what was reported by O'Bradovich
(33) in experiments where increased pulmonary microvascular permeability occurred
during air embolism in sheep and in dogs on the basis of endothelial damage (2)
independently of the activation of the contact system. Previous observations
in sheep of pulmonary damage produced by intravenous infusion of air bubbles have
similarly suggested the absence of activation of the coagulation system in this
particular experimental situation (9) .
The degree of contribution of surface activation of blood and cells in
the pathogenesis of dysbaric disorders in man remains unsettled. While our
results indicate the lack of activity of the system in our particular
experimental situation, differences exist between counterdiffusion venous gas
embolism and other forms of gas embolism. These include bubble size and
composition, sites of origin and rate of generation, and the still unexplained
absence of visible pulmonary injury in this model. It is not conceivable that
initial aspects of gas lesion formation in the pathogenesis of decompression
sickness and isobaric embolism are fundamentally different, even though gases
may differ. The lack of participation of the contact system in gas
bubble=mediated injury has also been documented in other animals (sheep and
dog), in situations in which the composition of the infused bubbles is identical.
This supports the concept that surface generated defense responses do not
constitute a primary and general pathogenic phenomenon of mild degrees of
10
dysbaric disorders. The observations of coagulation abnormalities in severe
cases of human decompression sickness could then be interpreted as secondary,
rather than as an initiating phenomenon.
The mechanisms leading to the multiple pathogenic effects observed in the
gas lesion diseases are complex, and elucidation of the contribution of these
mechanisms remains of critical importance in the rational prevention and
treatment of these related diseases. Isobaric counterdiffusion gas lesion
generation has provided an excellent experimental tool for the in-vivo
investigation of these mechanisms. Under the experimental conditions,
physiologic disruptions associated with extensive distribution of gas bubbles
in tissue and blood have been found to occur independent of activation of the
contact system and coagulation.
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TABLE 1 (Appendix C)
BLOOD CONTACT AND COAGULATION FACTORS
IN SUPERFICIAL ISOBARIC VENOUS EMBOLISM
Observation Animals
Factor XIII
(U/ml)
Factor XI
(U/ml)
Prekallikrein
(U/ml)
High Mol Wt
Kininogen
(U/ml)
Partial
Thromboplastin
Time (sec)
Prothrombin
Time
(sec)
Fibrinogen(mg/dl)
Baseline
0.54 + 0.06
1.21 + 0.04
0.91 + 0.02
1.48 + 0.12
23.8 + 1.6
9.9 + 0.3
156 + 24
Counterdiffusion
2.4 Hours
0.76 ± 0.12
1.14 ± 0 . 0 8
0.83 ± .12
1.54 ± 0.19
23.2 ± 2.3
9.9 ± 0.2
170 + 29
5.2 Hours
0.51 ± 0.06
0.90 ± 0.12*
0.65 ± 0.10*
1.17 ± 0.22
24 .4 + 4.0
10.1 + 0.4
214 + 28*
* = significant change from Baseline (p -^.05)
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APPENDIX D
APPENDIX D.
PRIOR STUDIES - INFUSION OF AIR BUBBLE EMBOLI INTO RIGHT ATRIUM OF SHEEP.
Method and Measurement. Effects on Pulmonary Microvascular
Ultrastructure. Relation to Pulmonary Lymph Flow.
(Extracted from Project Proposal Summary of studies conducted by
Co-Principal Investigator, K. Albertine, with colleagues at University of
California - San Francisco, and at the University of South Florida) (Reference
(1), this Report).
Extract:
Time course of damage to pulmonary microvascular ultrastrueture was
related to changes in pulmonary arterial hemodynamics and lung lymph flow in
anesthetized, ventilated sheep with lung lymph fistulas (Controls, one-hour
air embolized, four-hour air embolized). Air bubble emboli (ca 1 mm diameter)
were infused after baseline measurements into the right atrium at a steady
rate sufficient to double control pulmonary arterial blood pressure. Control
(non-embolized sheep) had stable hemodynamics and lymph flow throughout a six-
hour experiment period.
Embolized sheep all showed qualitatively similar effects. Lymph flow
increased by one hour and became more elevated at four hours. Lymph protein
concentration remained constant relative to plasma protein concentration,
compatible with increased microvascular permeability to plasma protein. At
four hours of embolization lymph "protein clearance" (protein concentration x
lymph flow) was three times the initial control value. Cardiac output was not
appreciably altered by the embolism. White blood cell counts were performed,
but information is not sufficient to indicate degree of a probable
leucocytosis.
A systematic plan of lung biopsy was carried out at the end point of
exposures, to provide for two forms of microscopic evaluation of tissue
changes. Terminally the thorax was opened, the right lung hilum cross-
clamped, and the left lung airways were filled with 2% glutaraldehyde-1%
paraformaldehyde fixative. The unfixed right lung was used for extravascular
lung water measurement and for frozen section histologic examination. The
left caudal lobe was used for examination by light and transmission electron
microscopy.
Frozen section histology of unfixed lung showed air bubbles throughout
the lung, in the pulmonary arterial microcirculation. Extravascular lung
water measurement indicated pulmonary edema by four hours of embolization. By
light microscopy (glycolmethacrylate sections) air bubbles were found only in
pulmonary arterial vessels (1000 to 11 m diameter). Leucocytes accumulated in
lungs, and aggregated about air bubble boundaries.
Ultrastructural examination showed development of gaps between
endothelial cell margins in pulmonary arterial microvessels (1000 to 100 m
diameter). Gaps were focal, with length reaching 3 m. Some endothelial cells
bordering gaps showed signs of ultrastructural damage, including retraction,
detachment, sloughing or necrosis. Some endothelial cell gaps were partially
plugged by platelets.
Neutrophils were the predominant type of leucocyte at the blood-gas
embolus interface, which was bordered by a membranous proteinaceous layer.
Neutrophils and, to a lesser extent, lymphocytes became associated with this
layer.
These preliminary studies involving infusions of air emboli have been
reported in the Journal of Applied Physiology (J. Appl. Physiol. Respirat.
Environ. Exercise Physical. 57(5): 1360-1368, 1984). They have indicated the
occurrence of structural and functional changes in pulmonary microvasculature,
even in the absence of states of decompression or counterdiffusion
supersaturation. and any peripheral effects generated in spontaneous gas
embolism.
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